my.bionity.com
With an accout for my.bionity.com you can always see everything at a glance – and you can configure your own website and individual newsletter.
21-10-2004: Austrianova announced that its primary
academic partner, The Research Institute of Virology and Biomedicine
at the Veterinary University of Medicine, has been granted a patent
from the European patent office. The proprietary technology relates
to a new kind of retroviral vector known as ReCon (reconstituting
vector).
"We are extremely pleased that this technology has been
deemed both novel and inventive" said Prof. Walter H. Günzburg, Head
of the Research Institute and a co-inventor. ReCon allows the
production of retroviral vectors carrying toxic or cytostatic genes
from vector producing cells and thus circumvents a common problem
encountered when using previous generations of retroviral vector.
The
exclusive licensee of this technology is the Research Institute's
partner, Austrianova. "We can apply these innovative vectors for the
treatment of solid tumours in combination with therapeutic genes that
can directly kill cancer cells" commented Brian Salmons, Managing
Partner: Science and Technology, Austrianova.
Watchlist
This is where you can add this news to your personal favourites
Austrianova discovers new therapeutic for cancer gene therapy
Austrianova, together with its partner at the Research Institute for Virology and Biomedicine, University of Veterinary Medicine have shown that a gene from a bacteriophage can be used for the treatment of cancer. The Department of Therapeutic Genes & Delivery Systems at Austrianova, headed ... more
Austrianova and the Research Institute of Virology & Biomedicine granted retroviral patent in Europe
Austrianova announced that its primary academic partner, The Research Institute of Virology and Biomedicine at the Veterinary University of Medicine, has been granted a patent from the European patent office. The proprietary technology relates to a new kind of retroviral vector known as ... more
Austrianova Biomanufacturing AG
AUSTRIANOVA Biomanufacturing AG, one of the leading Austrian biotech companies, is focused on the development and manufacture of highly innovative tumour treatments based on localized cell therapies. The company has established a unique and versatile cGMP-compliant cell encapsulation platf ... more
Austrianova Biomanufacturing AG
AUSTRIANOVA Biomanufacturing AG, one of the leading Austrian biotech companies, is focused on the development and manufacture of highly innovative tumour treatments based on localized cell therapies. The company has established a unique and versatile cGMP-compliant cell encapsulation platf ... more
Austrianova and the Research Institute of Virology & Biomedicine granted retroviral patent in Europe
Austrianova announced that its primary academic partner, The Research Institute of Virology and Biomedicine at the Veterinary University of Medicine, has been granted a patent from the European patent office. The proprietary technology relates to a new kind of retroviral vector known as ... more
Veterinärmedizinische Universität Wien
The University of Veterinary Medicine is the only academic and research institution in Austria that focusses on the veterinary sciences and the oldest such institution in the German-speaking world. It was founded in 1765. Since 1996 the university campus has been located in the 21st distr ... more
Über CHEMIE.DE
CHEMIE.DE Information Service GmbH runs specialist scientific internet portals. The secret to our success? We are familiar with what we publish.
Advertising at CHEMIE.DE
Our advertising formats support you in getting your message across to a clearly defined target audience.
© 1997-2013 CHEMIE.DE Information Service GmbH, All rights reserved
Netmeeting
